scispace - formally typeset
S

Sunil K. Aggarwal

Researcher at University of Washington

Publications -  24
Citations -  702

Sunil K. Aggarwal is an academic researcher from University of Washington. The author has contributed to research in topics: Cannabis & Palliative care. The author has an hindex of 11, co-authored 22 publications receiving 522 citations. Previous affiliations of Sunil K. Aggarwal include New York University & Rusk Institute of Rehabilitation Medicine.

Papers
More filters
Journal ArticleDOI

Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions.

TL;DR: The current and emerging research on the physiological mechanisms of cannabinoids and their applications in managing chronic pain, muscle spasticity, cachexia, and other debilitating problems are reviewed.
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.
Journal ArticleDOI

Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State

TL;DR: Data indicate that males and females access MC at approximately the same rate, with similar median authorization times, and major treatment access and delivery barriers remain.
Journal ArticleDOI

Cannabinergic pain medicine: a concise clinical primer and survey of randomized-controlled trial results.

TL;DR: This article attempts to cover pragmatic clinical considerations involved in the use of cannabinergic medicines in pain practice, including geographical and historical considerations, pharmacokinetics, pharmacodynamics, adverse effects, drug interactions, indications, and contraindications.
Journal ArticleDOI

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.

TL;DR: Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.